The Top Pharma Acquisitions of 2012 (AZN, BMY, GSK):
"Pharma largely backed off mergers and acquisitions this year, but there were still a couple of deals earning attention. Bristol-Myers Squibb (NYSE: BMY ) and AstraZeneca (NYSE: AZN ) made a significant diabetes play. GlaxoSmithKline (NYSE: GSK ) absorbed a pipeline partner with a small stable of drugs. The deals helped these big pharma players diversify their portfolio and offset revenues lost to patent expirations."
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
Wednesday, January 2, 2013
2012 - Top Pharma Acquisitions (AZN, BMY, GSK)
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment